Similarly, the selective Src family kinase inhibitor PP2 notably blocked IFN-mediated CLL cell survival by downregulating the protein levels of STAT3 and Mcl-1. This evidence concerns the gene STAT3 and B-cell chronic lymphocytic leukemia.